✨ Your Portfolio is fetched and updated from zerodha.
Market Cap
₹645 Cr.
P/E
9.77
About
Andhra Petrochemicals limited is engaged in the manufacture and sale of oxo alcohols. The oxo alcohol products are ethyl hexanol, normal butanol and iso butanol. Following are the facilities offered … Read more
Andhra Petrochemicals limited is engaged in the manufacture and sale of oxo alcohols. The oxo… Read more
Low
70
52W Range
High
127
  • Andhra Petrochem
  • Vinyl Chemicals
  • Titan Bio-Tech
  • TJI Chemicals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
100 %
(as of Mar 20)
Oxo-alcohols - Domestic Capacity Market Share
35 %
(as of Mar 20)
Oxo-alcohols - Market Share
Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Raw Material Break-Up

Operational Metrics

    Select a Metric
    • Capacity Utilization - Oxo-Alcohols (%)
    • Manufacturing Capacity - Oxo-Alcohols (MTPA)
    • Realization/Tonne - Oxo-Alcohols (Rs/MT)
    Peer Comparison
    FAQs on Andhra Petrochemicals Ltd. Business

    Andhra Petrochemicals Limited specializes in the manufacturing and sale of oxo alcohols such as ethyl hexanol, normal butanol, and iso butanol, while also providing storage, steam generation, power generation, and cooling tower facilities.

    Andhra Petrochem major competitors are Vinyl Chemicals, Titan Bio-Tech, Indo Borax & Chem., Black Rose Inds., Sunshield Chemicals, Multibase India, Amal.
    Market Cap of Andhra Petrochem is ₹645 Crs.
    While the median market cap of its peers are ₹640 Crs.

    Andhra Petrochem seems to be less financially stable compared to its competitors.
    Altman Z score of Andhra Petrochem is 5.72 and is ranked 6 out of its 8 competitors.

    Company Filing
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Sep Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis